tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders StocksMarket MoversTipRanks 50 IndexAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by UpsideTop ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Research Tools
Trending StocksCompare StocksCompare ETFsTrump Dashboard
New
Daily Feeds
Daily Analyst RatingsDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Class Actions
Stock ScreenerETF Screener
Popular
Penny Stock ScreenerTechnical Analysis Screener
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Trending News
More News >
Education
Personal FinanceHow To Use TipRanksTipRanks LabsWebinar CenterGlossaryFAQs
About Us
About TipRanksContact UsCareersReviewsMobile APP
Working with TipRanks
Enterprise SolutionsAdvertise with UsTop Online BrokersBecome an AffiliateTipRanks News Wire
Follow Us
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders Stocks
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Trump Dashboard
New
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Enterprise Solutions
Plans & Pricing
Education
How To Use TipRanks
TipRanks Labs
Webinar Center
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
BioInvent International AB (BOVNF)
OTHER OTC:BOVNF
US Market
BOVNF
BioInvent International AB
Overview
Analyst Forecasts
Dividends
Earnings
Ownership
Financials
Statistics
New
Technical Analysis
Historical Prices
New
News & Insights
Chart
RESEARCH TOOLS
Top Analyst Stocks
Top Smart Score Stocks
Stock Screener
reports
Advertisement

BioInvent International AB (BOVNF) Stock News & Sentiment

Compare
4 Followers
BioInvent Reports Strong Q2 2025 Earnings and Clinical Progress
Premium
Company Announcements
BioInvent Reports Strong Q2 2025 Earnings and Clinical Progress
4d ago
BioInvent Restructures Portfolio to Focus on Lead Cancer Immunotherapy Programs
Premium
Company Announcements
BioInvent Restructures Portfolio to Focus on Lead Cancer Immunotherapy Programs
5d ago
BioInvent Sharpens Focus on Advanced Clinical Assets for Growth
Premium
Company Announcements
BioInvent Sharpens Focus on Advanced Clinical Assets for Growth
5d ago
BioInvent and Transgene to Present Promising BT-001 Study Results at ESMO 2025
Premium
Company Announcements
BioInvent and Transgene to Present Promising BT-001 Study Results at ESMO 2025
1M ago
BioInvent’s BI-1808 Shows Promising Results in Phase 2a CTCL Study
Premium
Company Announcements
BioInvent’s BI-1808 Shows Promising Results in Phase 2a CTCL Study
3M ago
BioInvent Reports Positive Phase 1 Results for Cancer Therapy
Premium
Company Announcements
BioInvent Reports Positive Phase 1 Results for Cancer Therapy
3M ago
BioInvent Showcases BI-1910 Development at PAGE 2025
Premium
Company Announcements
BioInvent Showcases BI-1910 Development at PAGE 2025
3M ago
More BOVNF News >

BOVNF News on the Web

Stifel Nicolaus Remains a Buy on BioInvent International AB (BOVNF)
TipRanks News
Neutral
BioInvent Reports Strong Q2 2025 Earnings and Clinical Progress
TipRanks News
Neutral
Invitation to Presentation of BioInvent's Year-end Report 2024
Yahoo Finance
Neutral
High Growth Tech Stocks In Sweden To Watch Now
Yahoo Finance
Neutral
BioInvent and Transgene’s Oncolytic Virus BT-001 Shows Promising Antitumor Activity in Ongoing Phase 1/2a Trial in Solid Tumors that Failed Previous Treatments
Yahoo Finance
Neutral
BioInvent Announces the Enrollment of the First Patient in Triple Combination Arm of BI-1206, Rituximab and Calquence for the Treatment of non-Hodgkin's Lymphoma
Yahoo Finance
Neutral
BioInvent and Transgene to Present Promising Initial Phase 1/2a Data on Oncolytic Virus, BT-001, at ESMO 2024
Yahoo Finance
Neutral
BioInvent Announces Additional Positive Efficacy Data with Single Agent BI-1808 from the Phase 2a anti-TNFR2 program
Yahoo Finance
Neutral

News Score - Last 7 Days

Neutral
BOVNF
Sector Average
Media Buzz
This Week2 articles
Weekly Average1 articles
News Sentiment
This Week50%
Sector Average56%
See how Bullish or Bearish a stock is based on its recent media coverage.

This score is generated using a formula that combines Media Buzz and News Sentiment.

Media Coverage Analysis

The historical news coverage of this asset in the last three months.

FAQ

What is BOVNF’s Media Buzz Sentiment?
2 articles about BOVNF were published this week. In an average week, 1 articles are published.
    What is BOVNF’s weekly average amount of articles?
    In an average week, 1 articles about BOVNF are published.
      What is BOVNF’s News Sentiment?
      50% of articles about BOVNF were positive this week, compared to its sector average of 56%.
        Healthcare Stocks that are Trending in the News
        COOCooper Co
        PAHCPhibro Animal Health
        ANSLFAnsell
        AAgilent
        WBAWalgreens Boots Alliance
        Showing the stocks with the most bullish news sentiment over the past week

        Become an Expert with TipRanks Premium

        What am I Missing?
        Make informed decisions based on Top Analysts' activity
        Know what industry insiders are buying
        Get actionable alerts from top Wall Street Analysts
        Find out before anyone else which stock is going to shoot up
        Get powerful stock screeners & detailed portfolio analysis
        Subscribe NowSee Plans & Pricing